Production and Characterization of OPK8801001, a Novel Long-Acting hGH Receptor Antagonist for the Treatment of Acromegaly June 2026 | OPKO Biologics
Extended-Release Calcifediol Identifies a Therapeutic Vitamin D Range in Chronic Kidney Disease stage 3-4 June 2026 | OXFORD Academic
New insights into the management of secondary hyperparathyroidism in non-dialysis dependent chronic kidney disease: extended release calcifediol June 2026 | Journal of Nephrology
Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity February 2026 | ScienceDirect
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom? August 2025 | PubMed
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial June 2025 | Karger